Wall Street Has Cooled on Moderna After Its Stock Jumped Over 5X. But Does the mRNA Leader Have More Room to Run?

The vaccine maker is making an increasingly robust case that it isn't just a pandemic stock.

CryptoAlerta — análise de criptomoedas e mercado em tempo real